Omada Health, Inc. (NASDAQ:OMDA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Omada Health, Inc. (NASDAQ:OMDA) has earned an average recommendation of “Moderate Buy” from the eleven research firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $25.10.

A number of analysts have recently issued reports on OMDA shares. Needham & Company LLC restated a “buy” rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Barclays cut their price target on Omada Health from $29.00 to $22.00 and set an “overweight” rating on the stock in a research note on Monday, January 5th. Morgan Stanley set a $32.00 price objective on shares of Omada Health in a research note on Thursday, December 18th. BMO Capital Markets assumed coverage on shares of Omada Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $27.00 price target for the company. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $26.00 price target on shares of Omada Health in a research report on Friday, January 16th.

Insiders Place Their Bets

In other news, President Wei-Li Shao sold 5,618 shares of the company’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $16.13, for a total transaction of $90,618.34. Following the transaction, the president owned 69,079 shares in the company, valued at $1,114,244.27. This represents a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sean P. Duffy sold 230,479 shares of Omada Health stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $15.60, for a total transaction of $3,595,472.40. Following the completion of the sale, the chief executive officer owned 126,644 shares of the company’s stock, valued at $1,975,646.40. This trade represents a 64.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 276,893 shares of company stock worth $4,336,787.

Institutional Investors Weigh In On Omada Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Strs Ohio purchased a new position in Omada Health during the third quarter valued at $38,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the 2nd quarter worth about $32,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health in the 4th quarter valued at about $32,000. Rakuten Investment Management Inc. acquired a new stake in Omada Health in the 3rd quarter worth about $49,000. Finally, Inlight Wealth Management LLC purchased a new stake in Omada Health during the 4th quarter worth approximately $45,000.

Omada Health Price Performance

NASDAQ:OMDA opened at $11.33 on Wednesday. The company has a market cap of $656.10 million and a price-to-earnings ratio of -45.32. Omada Health has a 1 year low of $10.70 and a 1 year high of $28.40. The stock’s 50 day simple moving average is $15.24 and its two-hundred day simple moving average is $19.54.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.